Hemostasis Today

November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
JAMA Neurology: No Added Benefit of Dual Therapy After Ischemic Stroke in Case of AFib
Jan 6, 2026, 13:39

JAMA Neurology: No Added Benefit of Dual Therapy After Ischemic Stroke in Case of AFib

JAMA Neurology shared on LinkedIn:

”In patients with ischemic stroke and concurrent nonvalvular atrial fibrillation and ASCVD, adding an antiplatelet agent to anticoagulant therapy offered no net clinical benefit over anticoagulant monotherapy.

Read the full article in JAMA.

Article: Optimal Antithrombotics for Ischemic Stroke and Concurrent Atrial Fibrillation and Atherosclerosis. A Randomized Clinical Trial

Authors: Shuhei Okazaki, Kanta Tanaka, Yukako Yazawa et al.

JAMA Neurology: No Added Benefit of Dual Therapy After Ischemic Stroke in Case of AFib

Stay updated on all scientific advances with Hemostasis Today.